154927-01-2

Basic information

• Product Name: 1-METHYL-5-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE
• Synonyms: 1-METHYL-5-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE;1-Methyl-5-phenyl-1H-pyrazole-4-carboxaldehyde;1-Methyl-5-phenyl-pyrazole-4-carbaldehyde
• CAS NO: 154927-01-2
• Molecular Formula: C₁₁H₁₀N₂O
• Molecular Weight: 186.21
• Mol File: 154927-01-2.mol

Chemical Properties

• Melting Point: 700℃
• Boiling Point: 356.4 °C at 760 mmHg
• Flash Point: 169.4 °C
• Appearance: /
• Density: 1.13±0.1 g/cm3 (20 ºC 760 Torr)
• Vapor Pressure: 2.92E-05mmHg at 25°C
• Refractive Index: 1.593
• Storage Temp.: 2-8°C
• PKA: 0.01±0.10(Predicted)
• CAS DataBase Reference: 1-METHYL-5-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-METHYL-5-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE(154927-01-2)
• EPA Substance Registry System: 1-METHYL-5-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE(154927-01-2)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• Hazardous Substances Data: 154927-01-2(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
1-Methyl-5-phenyl-1H-pyrazole-4-carbaldehyde is used as a building block for the synthesis of various pharmaceuticals. Its unique structure and reactivity make it a valuable component in the development of new drugs and medications.
Used in Agrochemical Industry:
1-Methyl-5-phenyl-1H-pyrazole-4-carbaldehyde is used as a starting material for the synthesis of agrochemicals. Its versatility in chemical reactions enables the creation of compounds that can be used in the development of pesticides, herbicides, and other agricultural products.
Used in Organic Synthesis:
1-Methyl-5-phenyl-1H-pyrazole-4-carbaldehyde is used as an intermediate in the synthesis of a variety of organic compounds. Its aldehyde group allows for further reactions, making it a key component in the production of numerous chemical products.

InChI:InChI=1/C11H10N2O/c1-13-11(10(8-14)7-12-13)9-5-3-2-4-6-9/h2-8H,1H3

Upstream product

• 3463-27-2 1-methyl-5-phenyl-1H-pyrazole 
• 68-12-2 N,N-dimethyl-formamide 

Relevant articles and documents

Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor

Phosphodiesterase 2A (PDE2A) inhibitors have been reported to demonstrate in vivo activity in preclinical models of cognition. To more fully explore the biology of PDE2A inhibition, we sought to identify potent PDE2A inhibitors with improved brain penetration as compared to current literature compounds. Applying estimated human dose calculations while simultaneously leveraging synthetically enabled chemistry and structure-based drug design has resulted in a highly potent, selective, brain penetrant compound 71 (PF-05085727) that effects in vivo biochemical changes commensurate with PDE2A inhibition along with behavioral and electrophysiological reversal of the effects of NMDA antagonists in rodents. This data supports the ability of PDE2A inhibitors to potentiate NMDA signaling and their further development for clinical cognition indications.

AGENT FOR PREVENTING OR TREATING NEUROPATHY

The present invention provides an agent for preventing or treating neuropathy having superior action and low toxicity. This agent comprises a compound represented by the formula:wherein ring A is a 5-membered aromatic heterocycle containing 2 or more nitrogen atoms, which may further have substituent(s);B is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group;X is a divalent acyclic hydrocarbon group;Z is -O-, -S-, -NR2-, -CONR2- or -NR2CO- (R2 is a hydrogen atom or an optionally substituted alkyl group);Y is a bond or a divalent acyclic hydrocarbon group;R1 is an optionally substituted cyclic group, an optionally substituted amino group or an optionally substituted acyl group, provided that when the 5-membered aromatic heterocycle represented by ring A is imidazole, then Z should not be -O-, or a salt thereof.